Queensland life sciences
clinical trials directory

The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

Women in Technology (WiT) is one of Australia’s biggest communities that support women in across all fields of science and technology. As a not-for-profit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential. For more than two decades we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy.

The Australian Institute of Tropical Health and Medicine (AITHM) is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM is focussed on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations.

WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.

Initially qualified in the Medical Laboratory Sciences, Trevor has been involved in the Healthcare/Biotechnology sector for >30 years in various roles of laboratory, sales, marketing, operational and general management of both multinationals, Australian and self-owned companies.

We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.

Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

The Gold Coast Health and Knowledge Precinct is a global business destination recognised for transforming lives through healthcare innovation, new knowledge and next-generation technologies.

USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.

Springfield City Group develops commercial, educational, healthcare, and residential real estate projects, with a vision of making Greater Springfield a sustainable regional city and services hub by 2030. BioPark Australia is to create a place where multiple biologic industries (Therapeutics, Vaccines, Med Tech, Diagnostics will co-locate and grow. Central to the BioPark will be its provision of the complete suite of necessary components and reagents for these industries. Future-proofing is built-in with staged expansion sites available to users.

The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.

Therapeutic Innovation Australia (TIA) provides a wide range of translational services. TIA works to lower the bar for researchers to access excellent translational research services in the fields of biologics, cell therapies, small molecules, preclinical testing and clinical trials.

Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.

Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.

Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.

PSC Biotech is a provider of life sciences essential services, ensuring the development, manufacturing, and distribution of medical and biotech products meet regulatory standards. The Australian team specializes in GMP Engineering, offering expertise in commissioning, qualification, and validation (CQV). They assist with validation project planning, documentation generation, execution, and summary reports. Additionally, PSC Biotech offers computer system validation (CSV) and technical writing support for operational readiness. Their focus is on maintaining compliance and delivering high-quality services in the life sciences industry.

Protagonist Therapeutics is a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.

Nucleus Network's Brisbane facility, formerly known as Q-Pharm, is a dedicated clinical trial unit situated at the Royal Brisbane and Women's Hospital. As Australia's second-largest Phase 1 unit, it conducts clinical trials for companies and researchers involved in developing new, safer, and more effective medications. With over 15 years of reliable experience, Q-Pharm has successfully completed over 400 Early Phase studies and recruited over 15,000 participants. Specializing in early-phase (phases 1 and 2) clinical trials, Q-Pharm operates in a cutting-edge facility located in the Herston precinct at the Royal Brisbane and Women's Hospital in Brisbane, Australia.

QBiotics Group is dedicated to improving the lives of people and animals by discovering and creating transformational pharmaceuticals derived from nature. Our primary programmes are in oncology and wound healing.

QIMR Berghofer Medical Research Institute is a world- leading translational research institute where research develops from the laboratory bench to the patient’s bedside. With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes.

Microbio is an Australian biotechnology startup that aims to revolutionise pathogen detection with our unique, specific, sensitive and fast pathogen identification test. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology.

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.

KE Select is an Australian based, leading Scientific & Medical Recruitment Partner for organisations within the Life Science, Medical, Clinical, Hospital and Healthcare space. Director Kerry McMahon, BSc Biomedical Science has over 15 years’ experience carrying out Executive Search, Permanent and Contract based recruitment projects in ANZ and more recently into APAC. Kerry and her team are passionate about tailoring every client’s needs. The focus for KE Select is to build and maintain personal longterm relationships.

Immunexpress is developing technology to accurately rule-in or rule-out sepsis in patients suspected of infection. Lack of reliable diagnostics leads to the over-treatment of sepsis, creating an overwhelming burden to healthcare systems, hospitals, clinicians, nurses, payers and antibiotic stewardship efforts. Our goal is to transform sepsis diagnostics by providing clinicians with the technology to rapidly enable and confidently make the right treatment decisions.

Kira Biotech is an Australian biotech company focused on developing immunomodulatory compounds to treat immune system disorders. Their lead candidate, KB312, is a selective monoclonal antibody that depletes activated immune cells, aiming to restore immune balance and tolerance. With venture capital funding, Kira Biotech is advancing KB312 through preclinical development and phase 1 clinical trials. The company is led by renowned rheumatologist and immunologist, Dr. Dan Baker, along with a team of drug development experts.

De Motu Cordis is a clinical based start up based in Brisbane that is developing a product platform for the emergency treatment of life-threatening conditions. DMC have developed a needle-free drug device combination for the immediate treatment of anaphalaxis.

Griffith University's Clinical Trial Unit, located within the Gold Coast Health and Knowledge Precinct and adjacent to the Gold Coast University Hospital, provides state-of-the-art facilities and professional coordination services to phase I-IV clinical trials. Supporting university staff and collaborators to conduct a wide range of trials, but also offering professional clinical trial site services to commercial clients such as global pharma, contract research organisations and the biotech and nutraceutical industry.

BiVACOR® is a privately held company founded in 2008.The BiVACOR is a total artificial heart designed to take over the complete function of a patient’s failing heart. The BiVACOR TAH is designed to be a long-term device that can replace the total function of the patient’s native heart.

Clinials is an AI-Driven clinical trial participant recruitment platform. We help researchers and pharmaceutical companies find eligible and engaged participants for their trials. Born in Brisbane, Australia – the world’s test bed for clinical trials, Clinials has global experience with clinical trial recruitment. .

Bellberry Limited is a national, private not-for-profit organisation providing streamlined scientific and ethical review of human research projects across Australia.

The Australian Institute for Bioengineering and Nanotechnology is an integrated multidisciplinary research institute bringing together world-class researchers and cutting-edge technology with a focus on translational research.

The principal goal of Avatar is to provide specialist insurance broking services to companies that develop innovative technology. Our key advantage is objective, in-depth research on industry-specific exposures. Avatar acts for 36% of the ASX listed Pharmaceuticals, Biotechnology & Life Sciences sector. They are the market leader in placement for emerging risks70% of their client base is derived from technology, life sciences, green energy & related service providers.

AusTrials is a leading private clinical research organisation, with dedicated and managed research sites in Australia. We are leaders in delivering phase II-IV interventional studies, capturing real world evidence and conducting observational research in the usual clinical setting.

360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment. Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas Expertise in virology, immunology and analytical chemistry. World-class facilities with BSL-2, BSL-3 & quarantine laboratories > Quality management systems to ensure that “every sample counts”

Beyond is an integrated product development team dedicated to early-stage product development, focusing primarily on advancing innovative products from small to medium biotechnology and pharmaceutical companies worldwide. As an Australian privately owned company, we provide flexible and nimble solutions to match the needs of our clients, whether it is a stand-alone activity or a full suite of services.

Experienced, tailored consulting in Research, Development and Innovation. We have been engaged with the Australian research ecosystem for over 20 years and understand the research funding landscape and the industry. Our consultants have advanced qualifications in their research field, experience working in that field, as well as consulting, business, legal and/or governance experience. Our combination of technical and business skills are critical to our approach. We prioritise positive, timely and accurate communication and high quality outputs.